Treatment of glaucoma using endothelin receptor antagonists | Patent Number 11738007

US 11738007 B2
Application Number17733216
Publication NumberUS 20220257568 A1
Pendency1 year, 4 months, 2 days
Filled DateApr 29, 2022
Priority DateOct 30, 2019
Publication DateAug 18, 2022
Expiration DateOct 29, 2039
Inventor/ApplicantsSevgi Gurkan
David Floyd
ExaminesANTHOPOLOS, PETER
Art Unit1611
Technology Center1600
Assignments
Perfuse Therapeutics Inc.
Current
Perfuse Therapeutics Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.